PTIX
Price:
$0.5
Market Cap:
$905.10K
Protagenic Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to the research and development of novel treatments designed to address neuropsychiatric and mood conditions exacerbated by stress. Foremost among its investigational products is PT00114, a laboratory-synthesized version of the teneurin carboxy-terminal associated peptide. This compound functions by emulating an innate brain signaling peptide, known for its ability to temper exaggerated stress reactions. The company's headquarters are located in New York, New York.
Industry
Biotechnology
IPO Date
2021-04-27
Stock Exchange
NASDAQ
Ticker
PTIX
According to Protagenic Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.85M. This represents a change of -69.47% compared to the average of 6.05M of the last 4 quarters.
The mean historical Enterprise Value of Protagenic Therapeutics, Inc. over the last ten years is 194.19M. The current 1.85M Enterprise Value has changed -4.82% with respect to the historical average. Over the past ten years (40 quarters), PTIX's Enterprise Value was at its highest in in the June 2021 quarter at 572.88M. The Enterprise Value was at its lowest in in the March 2016 quarter at -3234563.12.
Average
194.19M
Median
225.22M
Minimum
3.46M
Maximum
327.86M
Discovering the peaks and valleys of Protagenic Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 971.32%
Maximum Annual Enterprise Value = 327.86M
Minimum Annual Increase = -89.12%
Minimum Annual Enterprise Value = 3.46M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 3.46M | -89.12% |
| 2024 | 31.78M | -46.08% |
| 2023 | 58.93M | -39.15% |
| 2022 | 96.85M | -66.09% |
| 2021 | 285.59M | -12.89% |
| 2020 | 327.86M | 1.16% |
| 2019 | 324.11M | -0.05% |
| 2018 | 324.26M | 0.01% |
| 2017 | 324.23M | 96.69% |
| 2016 | 164.84M | 971.32% |
The current Enterprise Value of Protagenic Therapeutics, Inc. (PTIX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
31.39M
5-year avg
95.32M
10-year avg
194.19M
Protagenic Therapeutics, Inc.’s Enterprise Value is greater than Salarius Pharmaceuticals, Inc. (-4623480.00), greater than Lipella Pharmaceuticals Inc. (-1222021.00), greater than Artelo Biosciences, Inc. (-6344153.00), less than Indaptus Therapeutics, Inc. (4.77M), greater than Silexion Therapeutics Ltd. (-665546.00), greater than Revelation Biosciences, Inc. (-9460412.00), greater than Carisma Therapeutics, Inc. (-1759745.00), greater than SciSparc Ltd. (-3730477.00), greater than GT Biopharma, Inc. (-4175034.00), greater than Psyence Biomedical Ltd. (-6071833.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -4623480.00 | $4.92M | |
| -1222021.00 | $369.67K | |
| -6344153.00 | $3.17M | |
| 4.77M | $6.27M | |
| -665546.00 | $1.31M | |
| -9460412.00 | $3.89M | |
| -1759745.00 | $255.25K | |
| -3730477.00 | $494.52K | |
| -4175034.00 | $4.75M | |
| -6071833.00 | $63.33K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protagenic Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Protagenic Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Protagenic Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Protagenic Therapeutics, Inc. (PTIX)?
What is the 3-year average Enterprise Value for Protagenic Therapeutics, Inc. (PTIX)?
What is the 5-year average Enterprise Value for Protagenic Therapeutics, Inc. (PTIX)?
How does the current Enterprise Value for Protagenic Therapeutics, Inc. (PTIX) compare to its historical average?